| Financial Year |
March 31 2023 |
| Monetary Funds |
641,524,154.58 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
21,820,496.66 |
| Advances to Suppliers |
6,728,704.48 |
| Other Receivables |
3,960,675.46 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
33,359,134.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,040,303.60 |
| Total Current Assets |
713,433,469.69 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
31,945.48 |
| Investment Properties |
-- |
| Fixed Assetes |
179,077,877.28 |
| Under-construction Projects |
57,267,045.91 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
35,709,897.45 |
| R&D expenses |
-- |
| Goodwill |
3,301,151.52 |
| Long-Term Deferred and Prepaid Expenses |
22,283,318.34 |
| Deferred Income Tax Assets |
4,167,730.60 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
364,989,226.94 |
| Total Assets |
1,078,422,696.63 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
21,393,649.44 |
| Accounts Received In Advance |
931,963.73 |
| Employee Compensation Payable |
1,136,566.89 |
| Taxes Payable |
5,432,858.61 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
5,040,999.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,624,974.39 |
| Other Current Liabilities |
393,380.68 |
| Sub-Total of Current Liabilities |
54,755,861.13 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,519,100.70 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
46,761,783.79 |
| Total Liabilities |
101,517,644.92 |
| Paid-In Capital(Or Share Stock) |
200,868,295.00 |
| Capital Surplus |
437,740,181.11 |
| Surplus Reserve |
62,053,528.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
276,209,738.24 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
976,905,051.71 |
| Owner's Equity（Stockholder's Equity） |
976,905,051.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,078,422,696.63 |
